| UCSF/MDI
Symposium
Drug
Design & Discovery
UCSF Laurel Heights
Conference Center
San Francisco, CA
October 13-14, 2000 |
 |
Over one hundred
and forty scientists from academia and industry worldwide met in San Francisco
on October 13-14, 2000, to discuss drug design and discovery in
the post genomics era. The meeting provided many interesting perspectives
on how the science and the technology of drug discovery are changing and
will continue to change in the era of combinatorial chemistry and genomics.
The meeting was sponsored by the Department
of Pharmaceutical Chemistry and the Molecular
Design Institute of the University of California San Francisco and
was chaired by Professors
Peter
Kollman, Ken Dill and
Irwin
Kuntz . Presentations and discussion dealt with challenges in
using current technologies and needs and prospects for the future.
KEYNOTE
ADDRESS
"Drug
Discovery in the Pharmaceutical Industry"
Paul
Anderson, Ph.D.
Senior
VP, Chemical and Physical Sciences
DuPont
Pharmaceuticals
Speakers and Chairs
Johan
Aqvist,
Uppsala
University
Paul Anderson,
Dupont
Pharmaceuticals
Ken
Dill, University of California San Francisco
David Diller,
Pharmacopeia
Robert
Fletterick, University of California San Francisco
Simon Kearsley,
Merck
Research Laboratories
Peter
Kollman,
University
of California San Francisco
Irwin
Kuntz, University
of California San Francisco
Robert McDowell,
Sunesis
Jon Mason, Bristol
Myers Squibb
David Pearlman,
Vertex
Pharmaceuticals
Tom
Scanlan, University of California San Francisco
Bruce
Tidor,
Massachusetts
Institute of Technology
Dennis Underwood,
DuPont
Pharmaceuticals
Gennady Verkhivker,
Agouron
Pharmaceuticals
Go
to : Meeting Program (Presentations and Schedule)
The schedule and
the meeting location fostered interaction at presentations and poster sessions
and at breaks and meals. Poster sessions provided the opportunity for all
who attended to present their recent results.
Sponsors
The "Drug Design
and Discovery" meeting gratefully acknowledges the financial support of:
Amgen, Axys Pharmaceuticals, DuPont Pharmaceuticals
Company, Genentech, Janssen Pharmaceutica, Kosan Biosciences, Molecular
Simulations, Pfizer La Jolla, University of California Life Sciences Informatics
Program, Vertex Pharmaceuticals.
UCSF
MDI Scientific Meetings Series
Figure
Created by Malin Young, the figure used
for the "Drug Design and Discovery" meeting and, in a different view, for
the Year 2000 DOCK User Group Meeting
is a cross sectional view of the active site of serine peptidases. Members
of this protease family were structurally aligned to trypsin and the variation
in the solvent accessible surfaces for the proteases in the binding pocket
is depicted using GRASP.
top
